Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 808

Similar articles for PubMed (Select 12579092)

1.

Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.

Lord RV, Park JM, Wickramasinghe K, DeMeester SR, Oberg S, Salonga D, Singer J, Peters JH, Danenberg KD, Demeester TR, Danenberg PV.

J Thorac Cardiovasc Surg. 2003 Feb;125(2):246-53.

PMID:
12579092
2.

Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.

Lord RV, Salonga D, Danenberg KD, Peters JH, DeMeester TR, Park JM, Johansson J, Skinner KA, Chandrasoma P, DeMeester SR, Bremner CG, Tsai PI, Danenberg PV.

J Gastrointest Surg. 2000 Mar-Apr;4(2):135-42.

PMID:
10675236
3.

Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.

Lord RV, Brabender J, Wickramasinghe K, DeMeester SR, Holscher A, Schneider PM, Danenberg PV, DeMeester TR.

Surgery. 2005 Nov;138(5):924-31.

PMID:
16291394
4.

Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence.

Lord RV, Tsai PI, Danenberg KD, Peters JH, Demeester TR, Tsao-Wei DD, Groshen S, Salonga D, Park JM, Crookes PF, Kiyabu M, Chandrasoma P, Danenberg PV.

Surgery. 2001 Mar;129(3):267-76.

PMID:
11231454
5.

Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.

Brabender J, Lord RV, Danenberg KD, Metzger R, Schneider PM, Park JM, Salonga D, Groshen S, Tsao-Wei DD, DeMeester TR, Hölscher AH, Danenberg PV.

J Surg Res. 2001 Aug;99(2):301-6.

PMID:
11469901
6.

The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.

Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.

J Pathol. 2003 Jun;200(2):183-94.

PMID:
12754739
7.

Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.

Brabender J, Lord RV, Wickramasinghe K, Metzger R, Schneider PM, Park JM, Hölscher AH, DeMeester TR, Danenberg KD, Danenberg PV.

J Gastrointest Surg. 2002 May-Jun;6(3):359-67.

PMID:
12022988
8.
9.

Expression of acidic fibroblast growth factor in Barrett's esophagus and associated esophageal adenocarcinoma.

Soslow RA, Ying L, Altorki NK.

J Thorac Cardiovasc Surg. 1997 Nov;114(5):838-43.

PMID:
9375615
10.

Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers.

Fujimoto J, Aoki I, Toyoki H, Khatun S, Tamaya T.

Ann Oncol. 2002 Oct;13(10):1605-11.

11.

Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.

Zou H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, Romero Y, Burgart LJ, Ahlquist DA.

Int J Cancer. 2005 Sep 10;116(4):584-91.

PMID:
15825175
12.

Acidic fibroblast growth factor is progressively increased in the development of oesophageal glandular dysplasia and adenocarcinoma.

Soslow RA, Nabeya Y, Ying L, Blundell M, Altorki NK.

Histopathology. 1999 Jul;35(1):31-7.

PMID:
10383711
13.

CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target.

Hansel DE, Dhara S, Huang RC, Ashfaq R, Deasel M, Shimada Y, Bernstein HS, Harmon J, Brock M, Forastiere A, Washington MK, Maitra A, Montgomery E.

Am J Surg Pathol. 2005 Mar;29(3):390-9.

PMID:
15725809
14.

Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers.

Nakata S, Ito K, Fujimori M, Shingu K, Kajikawa S, Adachi W, Matsuyama I, Tsuchiya S, Kuwano M, Amano J.

Int J Cancer. 1998 Apr 17;79(2):179-86.

PMID:
9583734
15.

Role of retinoid X receptor mRNA expression in Barrett's esophagus.

Brabender J, Lord RV, Metzger R, Park J, Salonga D, Danenberg KD, Hölscher AH, Danenberg PV, Schneider PM.

J Gastrointest Surg. 2004 May-Jun;8(4):413-22.

PMID:
15120365
16.

Molecular determinants in targeted therapy for esophageal adenocarcinoma.

Vallböhmer D, Peters JH, Kuramochi H, Oh D, Yang D, Shimizu D, DeMeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, Danenberg PV, DeMeester TR.

Arch Surg. 2006 May;141(5):476-81; discussion 481-2.

PMID:
16702519
17.

Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma.

Pizzi M, Fassan M, Realdon S, Balistreri M, Battaglia G, Giacometti C, Zaninotto G, Zagonel V, De Boni M, Rugge M.

Hum Pathol. 2012 Nov;43(11):1839-44. doi: 10.1016/j.humpath.2012.01.004. Epub 2012 Apr 20.

PMID:
22521076
18.

Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer.

Ohta Y, Endo Y, Tanaka M, Shimizu J, Oda M, Hayashi Y, Watanabe Y, Sasaki T.

Clin Cancer Res. 1996 Aug;2(8):1411-6.

19.

Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.

Sipos B, Weber D, Ungefroren H, Kalthoff H, Zühlsdorff A, Luther C, Török V, Klöppel G.

Int J Cancer. 2002 Dec 20;102(6):592-600.

PMID:
12448000
20.

Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa.

André T, Kotelevets L, Vaillant JC, Coudray AM, Weber L, Prévot S, Parc R, Gespach C, Chastre E.

Int J Cancer. 2000 Apr 15;86(2):174-81.

PMID:
10738243
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk